Effect of c-Met and CD44v6 Expression in Resistance to Chemotherapy in Esophageal Squamous Cell Carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of c-Met and CD44v6 Expression in Resistance to Chemotherapy in Esophageal Squamous Cell Carcinoma
Authors
Keywords
-
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-05
DOI
10.1245/s10434-018-07126-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic Tumor Volume Change Predicts Long-term Survival and Histological Response to Preoperative Chemotherapy in Locally Advanced Esophageal Cancer
- (2018) Tomoki Makino et al. ANNALS OF SURGERY
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Tivantinib in Combination with Erlotinib versus Erlotinib Alone for EGFR- Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE Study
- (2018) Giorgio V. Scagliotti et al. Journal of Thoracic Oncology
- Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
- (2018) Lorenza Rimassa et al. LANCET ONCOLOGY
- C-Met as a potential target for the treatment of gastrointestinal cancer: Current status and future perspectives
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR PHYSIOLOGY
- New evidence guiding extent of lymphadenectomy for esophagogastric junction tumor
- (2017) Bin Zheng et al. MEDICINE
- Foretinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-Met
- (2017) Guang-Zong Chen et al. Journal of Cancer
- Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer
- (2017) K. Yamashita et al. DISEASES OF THE ESOPHAGUS
- Solitary Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma: Surgical Failure or Systemic Disease?
- (2016) Tomoki Makino et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma
- (2016) Haixing Wang et al. TUMOR BIOLOGY
- Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib
- (2016) Lorenza Rimassa et al. Oncotarget
- C-Met as a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome
- (2016) Ya-Ping Xu et al. Journal of Cancer
- Cancer Stem Cell Signaling during Repopulation in Head and Neck Cancer
- (2016) George D. Wilson et al. Stem Cells International
- Clinical Importance of Supraclavicular Lymph Node Metastasis After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
- (2015) Hiroshi Miyata et al. ANNALS OF SURGERY
- Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
- (2015) Yingying Xu et al. BMC CANCER
- c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target
- (2015) Yohei Ozawa et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer
- (2015) Bangli Hu et al. MEDICINE
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer
- (2013) H. Miyata et al. BRITISH JOURNAL OF SURGERY
- Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
- (2013) Austin M Dulak et al. NATURE GENETICS
- Comparative Genomics of Esophageal Adenocarcinoma and Squamous Cell Carcinoma
- (2012) Santhoshi Bandla et al. ANNALS OF THORACIC SURGERY
- In vitro analysis of ovarian cancer response to cisplatin, carboplatin and paclitaxel identifies common pathways that are also associated with overall patient survival
- (2012) E Bicaku et al. BRITISH JOURNAL OF CANCER
- A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
- (2011) Nobutoshi Ando et al. ANNALS OF SURGICAL ONCOLOGY
- Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis
- (2011) Shuyang Sun et al. INTERNATIONAL JOURNAL OF CANCER
- Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer
- (2011) Francesca De Bacco et al. JNCI-Journal of the National Cancer Institute
- c-MET as a potential therapeutic target and biomarker in cancer
- (2011) J. Rafael Sierra et al. Therapeutic Advances in Medical Oncology
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis
- (2009) M. Tremmel et al. BLOOD
- Identification of CD44v6+/CD24− breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies
- (2009) Eric L Snyder et al. LABORATORY INVESTIGATION
- Crosstalk in Met receptor oncogenesis
- (2009) Andrea Z. Lai et al. TRENDS IN CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started